We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Test Shows Promise for Early Detection of Dementia

By LabMedica International staff writers
Posted on 19 Mar 2025

Idiopathic REM sleep behavior disorder (iRBD) causes individuals to physically act out their dreams while sleeping. More...

This disorder is strongly linked to a high risk of developing Parkinson’s disease and a related condition known as Dementia with Lewy Bodies (DLB). DLB is a type of dementia that leads to memory and cognitive decline, as well as vivid visual hallucinations and motor difficulties similar to Parkinson’s. Early detection of dementia risk could significantly influence how doctors manage patient care, allowing them to plan ahead and potentially offer more tailored, effective treatments. Now, a simple blood test could offer the potential to predict dementia development years before symptoms manifest in those with this sleep disorder.

Researchers at McGill University (Quebec, Canada) have found that a blood test initially created to detect Alzheimer’s disease could also help identify which iRBD patients are at higher risk of developing Dementia with Lewy Bodies. This test measures two proteins in the blood that are biomarkers for Alzheimer’s. In the study, the researchers followed 150 iRBD patients, taking annual blood samples to test for the biomarkers and tracking their health over time.

Remarkably, the blood test conducted four years prior successfully predicted dementia in nearly 90% of the patients who eventually developed the condition. Published in the journal Brain, the study also suggests that the early stages of Parkinson’s and Alzheimer’s share more similarities than previously recognized. The research team plans to expand the study to evaluate the test’s ability to predict dementia risk in individuals already diagnosed with Parkinson’s disease and in other groups at risk for Dementia with Lewy Bodies.

"Our findings suggest that Alzheimer’s treatments could also be tested in patients with this sleep disorder. Perhaps, if treatments start early enough, Dementia with Lewy Bodies can be prevented,” said first author Dr. Aline Delva.


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.